Editorial Volume 11, Issue 13 pp 4305—4307

A preclinical model for phenogroup 3 HFpEF

Keyvan Yousefi 1, 2, , Julian C. Dunkley 3, , Lina A. Shehadeh 2, 3, 4, 5, ,

  • 1 Department of Molecular and Cellular Pharmacology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA
  • 2 Interdisciplinary Stem Cell Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA
  • 3 Department of Medicine, Division of Cardiology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA
  • 4 Vascular Biology Institute, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA
  • 5 Peggy and Harold Katz Family Drug Discovery Center, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, USA

received: June 21, 2019 ; published: July 15, 2019 ;

https://doi.org/10.18632/aging.102102
How to Cite

Copyright: Yousefi et al. This is an open‐access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.